Orange Ventures
78, rue Olivier de Serres, Paris, Ile-de-France, 75015, France
Overview
Orange Ventures is a venture fund investing in areas of Orange expertise and beyond, with financial objectives in line with VC industry standards. With 350m€ assets under management, Orange Ventures is in the top 10 corporate ventures in Europe with an investment strategy focused on helping future global tech champions, fostering innovation in the Middle East and Africa, and supporting new sustainable and responsible business models.
- Total investments
- 52
- Lead investments
- 16
- Investments · 12mo
- 5
- Active investors
- 8
Sector focus
- Big Data
- Enterprise Software
- Finance
- Financial Services
- FinTech
- Internet of Things
- Venture Capital
- Wireless
Investment portfolio
- Multiverse Computing
Participated · Series C · Jul 2026
Founded in 2019 in San Sebastián, Multiverse Computing builds AI solutions inspired by quantum computing techniques—notably tensor-network approaches—to compress large language models and produce energy-efficient AI. The company says its technology can reduce model size and energy use by up to 95%, deliver 4x–12x faster inference, and cut costs by 50%–80%, enabling deployment on constrained devices like smartphones, laptops and satellites. Multiverse has launched a new generation of optimized models, including an open-source model and a family of compressed models designed for resource-limited environments. It has formed strategic partnerships with firms such as Cohere, Axelera AI, Plain Concepts, Inetum, EY and PwC to accelerate adoption in finance, energy, logistics, space, health and defense. Financially, Multiverse closed a €189M Series B in June 2025 (led by Bullhound Capital and including SETT and other investors) and is currently finalizing a larger round that could total €500M, backed in part by a €107M SETT commitment.
- Sêmeia
Participated · Equity · Jun 2026
Sêmeia develops MedicWise, a digital medical device and platform for remote monitoring of patients with chronic illnesses, aggregating data from lab analyses, connected medical devices and health reimbursement histories. Founded in 2017 in Toulouse, the company initially focused on nephrology and transplantation and has expanded into pneumology, rheumatology, oncology and mental health. MedicWise is used in more than 500 healthcare establishments to monitor about 35,000 patients. Sêmeia analyzes longitudinal clinical data to detect anomalies or deterioration between consultations and routes alerts to care teams. In 2022 the company raised €8 million and acquired competitor Optim’Care to strengthen its position in chronic kidney disease monitoring. With the new funding, Sêmeia plans to broaden specialty coverage, build AI-driven services to prioritize alerts and anticipate complications, and continue pursuing external growth.
- Chari
Led · Series A · Oct 2025
Founded in 2020 by husband-and-wife team Ismael and Sophia Belkhayat, Chari began as a mobile marketplace enabling corner shops to procure fast-moving consumer goods directly from distributors. The company has since evolved toward a banking-as-a-service model, using its recently obtained payment-institution licence from Bank Al-Maghrib to embed digital payments, credit, and other financial tools inside its merchant app. More than 20,000 small retailers across Morocco, Tunisia, and Côte d’Ivoire now use Chari’s platform, making it one of the region’s largest informal-retail digitisation plays. With a “super app” approach, Chari aims to transform these mom-and-pop stores into grassroots financial access points for underbanked communities. Future plans include opening its in-house financial rails to third-party developers, positioning the startup as a regional fintech enabler across Francophone Africa. To date, Chari has raised roughly $17 million in venture funding, which supports both its commerce logistics operations and the build-out of its fintech infrastructure.
- Rofim
Participated · Equity · Sep 2025
Rofim operates a digital tele-expertise platform that connects hospital clinicians to facilitate remote consultations and diagnostic collaboration. Positioned as a leader in French hospital telemedicine, the company already works with a large network of healthcare institutions and plans to onboard 400 additional establishments within the next year. Rofim’s technology enables secure video consultations and clinical data sharing, aiming to improve care pathways and reduce patient transfer times. With fresh capital, the company intends to accelerate product development and begin deployment across other European markets. The three co-founders remain majority shareholders, underscoring continued founder control. The firm previously secured €4.4 million in 2021 and has now strengthened its balance sheet with the new raise. No revenue or user metrics were disclosed in the article, but the company emphasizes its market-leading position in hospital telemedicine in France.
- Nucleon Security
Participated · Seed · Sep 2025
Nucleon Security designs and deploys automated, intelligent cybersecurity solutions based on agentic AI, with a platform that spans the full defense cycle. Its product suite includes a Zero Trust endpoint detection and response (EDR) system, a sovereign managed detection and response (MDR) service, Malprob AI for advanced malware analysis, and ScorX for alert prioritization. The company already supports over 100 clients across Africa, including organizations in Tunisia, Côte d’Ivoire, Burkina Faso, Nigeria, and Madagascar. Founded in 2019 in Morocco, Nucleon aims to industrialise its agentic AI Zero Trust platform and make proactive cybersecurity accessible across the continent. The firm plans to use new capital to accelerate international expansion and deepen R&D on its Zero Trust solutions. The company positions its automation as a response to a chronic shortage of cybersecurity professionals and rising global cybercrime costs cited in the article.